A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

Coombes, RC; Hall, E; Gibson, LJ; Paridaens, R; Jassem, J; Delozier, T; Jones, SE; Alvarez, I; Bertelli, G; Ortmann, O; +17 more... Coates, AS; Bajetta, E; Dodwell, D; Coleman, RE; Fallowfield, LJ; Mickiewicz, E; Andersen, J; Lønning, PE; Cocconi, G; Stewart, A; Stuart, N; Snowdon, CF; Carpentieri, M; Massimini, G; Bliss, JM; van de Velde, C; Intergroup Exemestane Study; (2004) A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. The New England journal of medicine, 350 (11). pp. 1081-92. ISSN 0028-4793 DOI: https://doi.org/10.1056/NEJMoa040331

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1056/NEJMoa040331

Abstract

Share

Download

Filename: nejmoa040331.pdf

Licence: Copyright the publishers

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar